MedPath

Domperidone

Generic Name
Domperidone
Drug Type
Small Molecule
Chemical Formula
C22H24ClN5O2
CAS Number
57808-66-9
Unique Ingredient Identifier
5587267Z69

Overview

A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.

Indication

For management of dyspepsia, heartburn, epigastric pain, nausea, and vomiting.

Associated Conditions

  • Diabetic Gastroparesis
  • Dyspepsia
  • Erosive Esophagitis
  • Gastrointestinal Symptoms
  • Non-erosive Reflux Esophagitis Disease (NERD)
  • Upper gastrointestinal motility disorders

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/08/01
N/A
Completed
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
2024/11/19
Phase 3
Not yet recruiting
University Hospital, Rouen
2022/10/06
Phase 3
Completed
2021/09/01
Phase 4
Completed
2021/08/09
N/A
AVAILABLE
2021/03/17
Phase 2
UNKNOWN
Dinara Zhumanbayeva
2021/01/07
Not Applicable
Recruiting
Children's Mercy Hospital Kansas City
2020/10/12
Phase 4
UNKNOWN
2019/09/26
Not Applicable
UNKNOWN
2019/07/18
N/A
Completed
Canadian Network for Observational Drug Effect Studies, CNODES

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
DOMPER SUPPOSITORY 10 mg
SIN09583P
SUPPOSITORY
10 mg
12/15/1997
GASTRIUM TABLET 10 mg
SIN10198P
TABLET
10 mg
10/8/1998
PEPTOMET TABLET 10 mg
SIN10180P
TABLET, FILM COATED
10 mg
10/6/1998
MOTILIUM TABLET 10 mg
SIN02500P
TABLET, FILM COATED
10 mg
3/14/1989
DOMPEL TABLET 10 mg
SIN10187P
TABLET
10 mg
10/6/1998
DORIDONE TABLET 10 mg
SIN10056P
TABLET, FILM COATED
10mg/tablet
9/28/1998
SAM CHUN DANG DOMPERIDONE TABLET 10 mg
SIN09202P
TABLET
10 mg
2/20/1997
DOMPER TABLET 10 mg
SIN06751P
TABLET
10 mg
12/30/1991
MOTILIUM SUSPENSION 1 mg/ml
SIN02891P
SUSPENSION
1 mg/ml
5/22/1989

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
MOTILIUM 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
55410
COMPRIMIDO RECUBIERTO CON PELÍCULA
Medicamento Sujeto A Prescripción Médica
Commercialized
DOMPERIDONA GAMIR 10 mg, CÁPSULAS DURAS
57096
CÁPSULA DURA
Medicamento Sujeto A Prescripción Médica
Commercialized
MOTILIUM 1 mg/ml SUSPENSION ORAL
55411
SUSPENSIÓN ORAL
Medicamento Sujeto A Prescripción Médica
Commercialized
DOMPERIDONA FLAS STADA 10 MG COMPRIMIDOS BUCODISPERSABLES EFG
Laboratorio Stada S.L.
81379
COMPRIMIDO BUCODISPERSABLE
Medicamento Sujeto A Prescripción Médica
Not Commercialized
DOMPERIDONA GAMIR 1mg/ml SUSPENSION ORAL
Meda Pharma S.L.
57151
SUSPENSIÓN ORAL
Medicamento Sujeto A Prescripción Médica
Not Commercialized

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.